Anticancer activities of Oldenlandia diffusa

Journal of Herbal Pharmacotherapy

Volumn 4, Issue 1, 2004, Pages 21-33

  Gupta, Salin ^a   Zhang, David ^b   Yi, Jizu ^b   Shao, Jun ^a  

^a ST JOHN'S UNIVERSITY   (United States)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Anticancer; Antiproliferative; Bai Hua She She Cao; Oldenlandia diffusa

Indexed keywords

ANTINEOPLASTIC AGENT; OLDENLANDIA DIFFUSA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG; WATER;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CHINESE HERB; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DNA DETERMINATION; DRUG EFFICACY; HUMAN; HUMAN CELL; IC 50; IN VITRO STUDY; LUNG METASTASIS; MICROSCOPY; MOUSE; NONHUMAN; OLDENLANDIA; OLDENLANDIA DIFFUSA; PANCREAS CELL; PRIORITY JOURNAL;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; APOPTOSIS; CELL LINE, TUMOR; CELL SURVIVAL; DNA FRAGMENTATION; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUGS, CHINESE HERBAL; LUNG NEOPLASMS; MICE; MICE, INBRED C57BL; NEOPLASMS; OLDENLANDIA; PLANT EXTRACTS;

EID: 1942439965     PISSN: 15228940     EISSN: None     Source Type: Journal    
DOI: 10.1300/J157v04n01_03     Document Type: Article

References (14)

1. American Cancer Society, Inc. Online document, www.cancer.org, January (2001).
2. D.M. Eisenberg, R.B. Davis, S.L. Ettner, S. Appel, S. Wilkey, and M. Van Rompay. Trends in Alternative Medicine Use in the United States, Journal of the American Medical Association, 18, 1569-1578 (1998).
3. M.A. Richardson, T. Sanders, J.L. Palmer, A. Greisinger, and S.E. Singletary. Complementary and Alternative Medicine Use in a Comprehensive Cancer Center and the Implications for Oncology, J Clin Oncol., 18(13), 2501-2504 (2000).
4. C. Lin, X. Lin, and J. Yang. An Observation on Combined Use of Chemotherapy and Traditional Chinese Medicine to Relieve Cancer Pain, J Tradit Chin Med., 16(4), 267-269 (1996).
5. J. Shao, J. Dai and J.K.H. Ma. A Pilot Study on Anti-Cancer Activities of Chinese Leeks, Journal of Alternative and Complementary Medicine, 7(5), 517-522 (2001).
6. S.L. Hu, Q. Chi, and Z.Z, Zhao. The Indigenous and Superior Chinese Herbal Drugs, Heilongjiang Science and Technology Press, 1989, pp. 555-556.
7. S.H. Kim and S.H. Ryu. Antitumor Effects of Ursolic Acid, Phytotherapy Research, 12, 553-556 (1998).
8. F. Lauthier, L. Taillet, C. Delage, and A. Simon. Ursolic Acid Triggers Calcium-Dependent Apoptosis in Human Daudi Cells, Anti-Cancer Drugs, 11 (9), 737-745 (2000).
9. Y. Yoshida, M.Q. Wang, B.E. Shan, and U. Yamashita. Immunomodulating Activity of Chinese Medicinal Herbs and Oldenlandia diffusa in Particular, Int J Immunopharmac., 19, 359-370 (1997).
10. Y.S. Wang. Pharmacology and Applications of Chinese Materia Medica, 1983, pp. 344-352.
11. T. Mosman. Rapid Colorimetric Assay for Cellular Growth and Survival: Application to Proliferation and Cytotoxicity Assays, J Immunol Meth., 65, 55-63 (1983).
12. S.H. Kim, B.Z. Ahn, and S.Y. Ryu. Antitumor Effects of Ursolic acid Isolated from Oldenlandia diffusa, Pytotherapy Research, 12(8), 553-556 (1999).
13. D. Es-saady, A. Simon, M. Ollier, J.C. Maurizis, A.J. Chulia, and C. Delege. Inhibitory Effect of Ursolic acid on B16-F10 Proliferation Through Cell Cycle Arrest, Cancer Letters, 106(2), 193-197 (1996).
14. J. Liu. Pharmacology of Oleanolic Acid and Ursolic Acid, J of Ethanopharmacology, 49(2-1), 57-68 (1995).